ArticlePoultry science2026
Attapulgite-enhanced probiotic delivery reprograms gut microbiota and metabolism to improve growth performance and immune function in broilers.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effects of attapulgite (APT) combined with Lactiplantibacillus plantarum (LP) and Limosilactobacillus reuteri (LR) on growth performance, intestinal barrier function, immune response, and cecal microbiota in broiler chickens, aiming to develop an effective antibiotic alternative. In vitro simulated gastrointestinal digestion demonstrated that APT significantly improved the survival of LP and LR, with scanning electron microscopy confirming bacterial adsorption onto APT. A total of 160 one-day-old broilers were assigned to dietary treatments, and growth performance, nutrient digestibility, serum biochemical and immunological indices, intestinal morphology, tight junction protein expression, cecal microbiota, and metabolomic profiles were analyzed. The combined APT-probiotic treatment significantly improved average daily gain and feed conversion ratio (P < 0.05), with effects comparable to antibiotic supplementation. It enhanced serum immunoglobulins (IgA, IgG, IgM) and IL-10 levels while reducing IL-6, and increased antioxidant capacity. Intestinal barrier integrity was improved, as indicated by increased villus height-to-crypt depth ratio and upregulation of ZO-1, Occludin, Claudin1, and MUC2. Microbiota analysis revealed enrichment of Bacteroidetes and short-chain fatty acid-producing genera, accompanied by increased concentrations of acetate, butyrate, and valerate (P < 0.05). Metabolomics further indicated enhanced pathways related to energy metabolism and antioxidant defense. In conclusion, APT-enhanced probiotic supplementation improves growth performance and gut health by modulating the microbiota-metabolite axis, highlighting its potential as a sustainable antibiotic alternative in poultry production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.